230 related articles for article (PubMed ID: 11689481)
1. Oligomerization of polyalanine expanded PABPN1 facilitates nuclear protein aggregation that is associated with cell death.
Fan X; Dion P; Laganiere J; Brais B; Rouleau GA
Hum Mol Genet; 2001 Oct; 10(21):2341-51. PubMed ID: 11689481
[TBL] [Abstract][Full Text] [Related]
2. HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy.
Fan X; Messaed C; Dion P; Laganiere J; Brais B; Karpati G; Rouleau GA
Can J Neurol Sci; 2003 Aug; 30(3):244-51. PubMed ID: 12945950
[TBL] [Abstract][Full Text] [Related]
3. Progress in understanding the pathogenesis of oculopharyngeal muscular dystrophy.
Fan X; Rouleau GA
Can J Neurol Sci; 2003 Feb; 30(1):8-14. PubMed ID: 12619777
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic targeting of mutant poly(A)-binding protein nuclear 1 suppresses protein aggregation and toxicity in oculopharyngeal muscular dystrophy.
Abu-Baker A; Laganiere S; Fan X; Laganiere J; Brais B; Rouleau GA
Traffic; 2005 Sep; 6(9):766-79. PubMed ID: 16101680
[TBL] [Abstract][Full Text] [Related]
5. PABPN1 polyalanine tract deletion and long expansions modify its aggregation pattern and expression.
Klein AF; Ebihara M; Alexander C; Dicaire MJ; Sasseville AM; Langelier Y; Rouleau GA; Brais B
Exp Cell Res; 2008 May; 314(8):1652-66. PubMed ID: 18367172
[TBL] [Abstract][Full Text] [Related]
6. Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA.
Calado A; Tomé FM; Brais B; Rouleau GA; Kühn U; Wahle E; Carmo-Fonseca M
Hum Mol Genet; 2000 Sep; 9(15):2321-8. PubMed ID: 11001936
[TBL] [Abstract][Full Text] [Related]
7. Oculopharyngeal muscular dystrophy.
Brais B; Rouleau GA; Bouchard JP; Fardeau M; Tomé FM
Semin Neurol; 1999; 19(1):59-66. PubMed ID: 10711989
[TBL] [Abstract][Full Text] [Related]
8. PABP2 polyalanine tract expansion causes intranuclear inclusions in oculopharyngeal muscular dystrophy.
Shanmugam V; Dion P; Rochefort D; Laganière J; Brais B; Rouleau GA
Ann Neurol; 2000 Nov; 48(5):798-802. PubMed ID: 11079546
[TBL] [Abstract][Full Text] [Related]
9. In vivo aggregation properties of the nuclear poly(A)-binding protein PABPN1.
Tavanez JP; Calado P; Braga J; Lafarga M; Carmo-Fonseca M
RNA; 2005 May; 11(5):752-62. PubMed ID: 15811916
[TBL] [Abstract][Full Text] [Related]
10. Oculopharyngeal muscular dystrophy: a late-onset polyalanine disease.
Brais B
Cytogenet Genome Res; 2003; 100(1-4):252-60. PubMed ID: 14526187
[TBL] [Abstract][Full Text] [Related]
11. Expression of the polyalanine expansion mutant of nuclear poly(A)-binding protein induces apoptosis via the p53 pathway.
Bhattacharjee RB; Zannat T; Bag J
Cell Biol Int; 2012 Aug; 36(8):697-704. PubMed ID: 22519734
[TBL] [Abstract][Full Text] [Related]
12. Ectopic expression of a polyalanine expansion mutant of poly(A)-binding protein N1 in muscle cells in culture inhibits myogenesis.
Wang Q; Bag J
Biochem Biophys Res Commun; 2006 Feb; 340(3):815-22. PubMed ID: 16378590
[TBL] [Abstract][Full Text] [Related]
13. Mammalian, yeast, bacterial, and chemical chaperones reduce aggregate formation and death in a cell model of oculopharyngeal muscular dystrophy.
Bao YP; Cook LJ; O'Donovan D; Uyama E; Rubinsztein DC
J Biol Chem; 2002 Apr; 277(14):12263-9. PubMed ID: 11796717
[TBL] [Abstract][Full Text] [Related]
14. Induction of HSP70 expression and recruitment of HSC70 and HSP70 in the nucleus reduce aggregation of a polyalanine expansion mutant of PABPN1 in HeLa cells.
Wang Q; Mosser DD; Bag J
Hum Mol Genet; 2005 Dec; 14(23):3673-84. PubMed ID: 16239242
[TBL] [Abstract][Full Text] [Related]
15. Oculopharyngeal muscular dystrophy-like nuclear inclusions are present in normal magnocellular neurosecretory neurons of the hypothalamus.
Berciano MT; Villagra NT; Ojeda JL; Navascues J; Gomes A; Lafarga M; Carmo-Fonseca M
Hum Mol Genet; 2004 Apr; 13(8):829-38. PubMed ID: 14976164
[TBL] [Abstract][Full Text] [Related]
16. Oculopharyngeal muscular dystrophy: recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategies.
Abu-Baker A; Rouleau GA
Biochim Biophys Acta; 2007 Feb; 1772(2):173-85. PubMed ID: 17110089
[TBL] [Abstract][Full Text] [Related]
17. Transgenic expression of an expanded (GCG)13 repeat PABPN1 leads to weakness and coordination defects in mice.
Dion P; Shanmugam V; Gaspar C; Messaed C; Meijer I; Toulouse A; Laganiere J; Roussel J; Rochefort D; Laganiere S; Allen C; Karpati G; Bouchard JP; Brais B; Rouleau GA
Neurobiol Dis; 2005 Apr; 18(3):528-36. PubMed ID: 15755680
[TBL] [Abstract][Full Text] [Related]
18. Cystamine suppresses polyalanine toxicity in a mouse model of oculopharyngeal muscular dystrophy.
Davies JE; Rose C; Sarkar S; Rubinsztein DC
Sci Transl Med; 2010 Jun; 2(34):34ra40. PubMed ID: 20519718
[TBL] [Abstract][Full Text] [Related]
19. Soluble expanded PABPN1 promotes cell death in oculopharyngeal muscular dystrophy.
Messaed C; Dion PA; Abu-Baker A; Rochefort D; Laganiere J; Brais B; Rouleau GA
Neurobiol Dis; 2007 Jun; 26(3):546-57. PubMed ID: 17418585
[TBL] [Abstract][Full Text] [Related]
20. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy.
Brais B; Bouchard JP; Xie YG; Rochefort DL; Chrétien N; Tomé FM; Lafrenière RG; Rommens JM; Uyama E; Nohira O; Blumen S; Korczyn AD; Heutink P; Mathieu J; Duranceau A; Codère F; Fardeau M; Rouleau GA
Nat Genet; 1998 Feb; 18(2):164-7. PubMed ID: 9462747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
